Vision-Sciences Appoints Cheryl Pegus, MD, MPH to Board of Directors
ORANGEBURG, N.Y., March 12, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc.
(Nasdaq:VSCI), a leading provider of unique flexible endoscopic products
utilizing its proprietary sterile disposable EndoSheath® technology, today
announced that Dr. Cheryl Pegus, a renowned cardiologist and physician
executive, has been appointed to the company's board of directors, effectively
Dr. Pegus has more than 24 years of clinical practice and medical management
experience. She currently is a Director of Glytec, LLC, a glycemic clinical
software organization in the forefront of in-patient diabetes management. She
is also a Strategic Advisor to HealthFleet, Inc., an online interactive
prevention company. Previously, she was Chief Medical Officer for Walgreens,
responsible for Clinical Affairs, Clinical Quality, Outcomes and Analytics,
Employee Health and Wellness, and Clinical Sales. From 2007-2010, she served
as the General Manager and founding Chief Medical Officer for SymCare
Personalized Health Solutions, a start-up company of Johnson & Johnson. She
also held positions of increasing responsibility at Aetna, including the Head
of Clinical Products for the Medical Products Business Unit, Inc. and early in
her career, served as Medical Director for the Cardiovascular Risk Factors
Group at Pfizer.
"We are pleased to welcome Dr. Pegus to the board," said Lewis C. Pell,
Chairman of the Vision-Sciences, Inc. board."Her significant accomplishments
and demonstrated track record of launching healthcare products will provide
invaluable insight as we seek to execute our strategy of growth and expansion
for our innovative EndoSheath technology."
"Dr. Pegus's impressive medical management skills have deservedly earned her
recognition as an outstanding, results-driven leader," added Cynthia Ansari,
President and Chief Executive Officer. "Her practical experience developing
successful relationships to expand market share complements our strategy to
drive awareness of our EndoSheath platform."
Commenting on her appointment, Dr. Pegus said, "I am delighted to join the
Vision-Sciences board and look forward to working with this experienced team.
The ease of use, safety and quality of the EndoSheath technology allows
clinicians to provide a cost-effective, accessible solution to multiple
populations. I hope to utilize my expertise and work with management to
advance the evidence base for this relevant technology."
Dr. Pegus is a board-certified physician with subspecialty training in
cardiology. She received a Masters in Public Health from Columbia University
School of Public Health, and an M.D. from Cornell University Medical College.
She is a Visiting Associate Professor, Department of Medicine, SUNY Downstate
Medical Center in Brooklyn, New York, and among other boards and affiliations,
she is the 2013 President-Elect of the American Heart Association (AHA),
Founder's Affiliate and a member of the Dean's Circle of Weill Cornell Medical
About Vision-Sciences, Inc.
Vision-Sciences, Inc. designs, develops, manufactures and markets products for
flexible endoscopy. The company's unique product lines feature a streamlined
visualization system and proprietary sterile disposable microbial barrier,
known as EndoSheath technology, providing users with efficient and cost
effective endoscope turnover while enhancing patient safety. Currently,
Vision-Sciences offers solutions for five main healthcare areas: urology,
pulmonology (critical care), gastroenterology (GI), ENT (ear, nose and throat)
and spine. Information about Vision-Sciences' products is available at
Vision Sciences^®, Slide-On^®, EndoSheath^®, EndoWipe^® and The Vision
System^® are registered trademarks of Vision-Sciences, Inc.
The Vision-Sciences, Inc. logo is available at
CONTACT: Keith Darragh
VP, Finance and Principal Financial and Accounting Officer
In-Site Communications, Inc.
Press spacebar to pause and continue. Press esc to stop.